Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117108) titled 'Association of Novel Serum-Derived Biomarkers of Inflammation, Metabolism, and Insulin Resistance in Coronary Heart Disease Patients with Hyperuricemia' on Jan. 20.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Northern Jiangsu People's Hospital
Condition:
CHD
Intervention:
Hyperuricemia group:none
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-01-20
Target Sample Size: Hyperuricemia group:500;Non-Hyperuricemia group:2000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?pro...